Physiological Study of High PEEP in Noninvasive Ventilation

March 25, 2026 updated by: Duan jun, Chongqing Medical University

A Physiological Study of High PEEP During Noninvasive Ventilation in Patients With Hypoxemic Respiratory Failure

To investigate the physiological effects of high positive end-expiratory pressure (PEEP) during noninvasive ventilation in patients with hypoxemic respiratory failure, and to elucidate the mechanisms underlying high PEEP-induced improvement in oxygenation.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, China, 400016
        • Recruiting
        • The First Affiliated Hospital of Chongqing Medical University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age ≥ 18 years
  2. PaCO₂ ≤ 50 mmHg
  3. PaO₂/FiO₂ ≤ 300 mmHg
  4. Use of a noninvasive ventilator with esophageal pressure monitoring capability (e.g., Mindray SV70) -

Exclusion Criteria:

  1. Respiratory failure caused by heart failure, asthma, or acute exacerbation of chronic obstructive pulmonary disease (COPD) (COPD as a comorbidity may be included)
  2. Pneumothorax
  3. Patients who refuse to participate in this trial -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High PEEP group
PEEP is increased stepwise from 5 cmH₂O, with increments of 5 cmH₂O every 10-20 minutes until reaching 20 cmH₂O. Once PEEP reaches or exceeds 20 cmH₂O, increments are made every 3-5 minutes until the recruitment level is achieved (i.e., stepwise increases to 5, 10, 15, 20, 25, and 30 cmH₂O). Inspiratory pressure is adjusted simultaneously to maintain a constant pressure difference.
First, PEEP was set at 5 cmH₂O, and inspiratory pressure was adjusted to achieve a target tidal volume of 6-8 mL/kg. Fraction of inspired oxygen (FiO₂) was titrated to maintain peripheral oxygen saturation (SpO₂) between 88% and 92%. Subsequently, PEEP was increased in 5 cmH₂O increments every 10-20 minutes from the initial value of 5 cmH₂O. Once PEEP reached 20 cmH₂O or above, increments were made every 3-5 minutes until the recruitment level was achieved (i.e., PEEP was increased stepwise from 5 to 10, 15, 20, 25, and 30 cmH₂O). Inspiratory pressure was adjusted concurrently to maintain a constant pressure difference. Throughout the procedure, physiological parameters-including respiratory rate, oxygenation, work of breathing, and others-were collected.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygenation
Time Frame: From enrollment to 2 hours post-intervention
The changes of SpO2/FiO2 from 5 to 30 cmH2O of PEEP.
From enrollment to 2 hours post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory rate
Time Frame: From enrollment to 2 hours post-intervention
Changes of respiratory rate from 5 to 30 cmH2O of PEEP
From enrollment to 2 hours post-intervention
Blood pressure
Time Frame: From enrollment to 2 hours post-intervention
Changes of blood pressure from 5 to 30 cmH2O of PEEP
From enrollment to 2 hours post-intervention
Heart rate
Time Frame: From enrollment to 2 hours post-intervention
Changes of heart rate from 5 to 30 cmH2O of PEEP
From enrollment to 2 hours post-intervention
Diaphragmatic excursion
Time Frame: From enrollment to 2 hours post-intervention
Changes in diaphragmatic excursion across PEEP levels from 5 to 30 cmH₂O. Diaphragmatic excursion refers to the movement of the thoracic diaphragm during breathing, as assessed by ultrasound.
From enrollment to 2 hours post-intervention
Diaphragm thickening fraction
Time Frame: From enrollment to 2 hours post-intervention
Changes in diaphragm thickening fraction across PEEP levels from 5 to 30 cmH₂O. Diaphragm thickening fraction is calculated based on the change in diaphragm thickness from end-expiration to end-inspiration ([end-inspiration - end-expiration]/end-expiration), as assessed by ultrasound.
From enrollment to 2 hours post-intervention
Work of breathing
Time Frame: From enrollment to 2 hours post-intervention
Changes in work of breathing across PEEP levels ranging from 5 to 30 cmH₂O were assessed by monitoring esophageal pressure with an esophageal balloon catheter.
From enrollment to 2 hours post-intervention
Electrical impedance tomography of the lung
Time Frame: From enrollment to 2 hours post-intervention
Changes in lung electrical impedance tomography were recorded across PEEP levels ranging from 5 to 30 cmH₂O. The electrical impedance tomography belt was placed around the chest at the level of the 4th to 5th intercostal spaces, and data were collected after the patient's breathing had stabilized.
From enrollment to 2 hours post-intervention
Tidal volume
Time Frame: From enrollment to 2 hours post-intervention
Changes of tidal volume from 5 to 30 cmH2O of PEEP
From enrollment to 2 hours post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jun Duan, MD, First Affiliated Hospital of Chongqing Medical University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 26, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

March 21, 2026

First Submitted That Met QC Criteria

March 25, 2026

First Posted (Actual)

March 31, 2026

Study Record Updates

Last Update Posted (Actual)

March 31, 2026

Last Update Submitted That Met QC Criteria

March 25, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • ChongqingMU07

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The informed consent form for this study clearly states that patients' data are only accessible to the research team and regulatory authorities when necessary, and shall not be disclosed to other individuals or institutions.Therefore, there is no plan to make data publicly available for this study.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Failure With Hypoxia

Clinical Trials on high PEEP

Subscribe